73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study finds 'startling' inequities in end-of-life opioid treatment

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in
Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b
Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t
Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr
Researchers create novel compound targeting melanoma cells

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re
New details revealed to explain how tumors recruit blood vessels

New details revealed to explain how tumors recruit blood vessels

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainA study by University of North Carolina Lineberger Comprehensive Cancer Center researchers helps explain

New details revealed to explain how tumors recruit blood vessels

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainA study by University of North Carolina Lineberger Comprehensive Cancer Center researchers helps explain
Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m

Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m
A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in
Study supports links between bovine meat and milk factor protein expression, inflammation as cause of colorectal cancer

Study supports links between bovine meat and milk factor protein expression, inflammation as cause of colorectal cancer

by WileyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Bovine meat and milk factors (BMMFs)—initially identified by de Villiers et al. in 2014—represent a class

Study supports links between bovine meat and milk factor protein expression, inflammation as cause of colorectal cancer

by WileyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Bovine meat and milk factors (BMMFs)—initially identified by de Villiers et al. in 2014—represent a class
Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre
Researchers identify potential target in myeloid malignancies

Researchers identify potential target in myeloid malignancies

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI165510Researchers at Children's Hospital of Philadelp

Researchers identify potential target in myeloid malignancies

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI165510Researchers at Children's Hospital of Philadelp
Family of DNA damage–inducing microbial metabolites found in guts of people with IBD

Family of DNA damage–inducing microbial metabolites found in guts of people with IBD

by Bob Yirka , Medical XpressHuman gut microbes isolated from IBD patients produce small-molecule genotoxins. Diverse gut microbes isolated from patients with IBD exhibit direct genotoxicity. M. morga

Family of DNA damage–inducing microbial metabolites found in guts of people with IBD

by Bob Yirka , Medical XpressHuman gut microbes isolated from IBD patients produce small-molecule genotoxins. Diverse gut microbes isolated from patients with IBD exhibit direct genotoxicity. M. morga